Aperio Group’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $566K | Buy |
31,421
+8,780
| +39% | +$158K | ﹤0.01% | 1904 |
|
|
2020
Q3 | $437K | Buy |
22,641
+6,066
| +37% | +$117K | ﹤0.01% | 1882 |
|
|
2020
Q2 | $433K | Buy |
+16,575
| New | +$433K | ﹤0.01% | 1830 |
|
|
2019
Q3 | – | Sell |
-91
| Closed | -$3K | – | 2741 |
|
|
2019
Q2 | $3K | Buy |
+91
| New | +$3K | ﹤0.01% | 2898 |
|